Orbimed Advisors LLC Scholar Rock Holding Corp Transaction History
Orbimed Advisors LLC
- $4.15 Billion
- Q2 2024
A detailed history of Orbimed Advisors LLC transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Orbimed Advisors LLC holds 1,074,382 shares of SRRK stock, worth $9.38 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
1,074,382
Previous 3,574,632
69.94%
Holding current value
$9.38 Million
Previous $63.5 Million
85.9%
% of portfolio
0.22%
Previous 1.43%
Shares
9 transactions
Others Institutions Holding SRRK
# of Institutions
170Shares Held
74.9MCall Options Held
151KPut Options Held
40.1K-
Artal Group S.A. Luxembourg, N411.3MShares$98.3 Million5.94% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.19MShares$71.5 Million0.01% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA6.79MShares$59.3 Million29.08% of portfolio
-
Black Rock Inc. New York, NY5.66MShares$49.5 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA5.45MShares$47.6 Million2.96% of portfolio
About Scholar Rock Holding Corp
- Ticker SRRK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,640,600
- Market Cap $451M
- Description
- Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...